Role of interleukin 12 in experimental neonatal sepsis caused by group B streptococci

Infection and Immunity

Volumn 65, Issue 9, 1997, Pages 3731-3735

  Mancuso, Giuseppe ^a   Cusumano, Vitaliano ^a   Genovese, Francesco ^a   Gambuzza, Maria ^a   Beninati, Concetta ^a   Teti, Giuseppe ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b Istituto di Microbiologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOPOIETIC CELL; LETHALITY; MENINGITIS; MOUSE; NEWBORN SEPSIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SEPTICEMIA; STREPTOCOCCUS AGALACTIAE;

EID: 0030921891     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.9.3731-3735.1997     Document Type: Article

References (38)

1. Baker, C. J. 1986. Group B streptococcal infections in newborns. N. Engl. J. Med. 314:1702-1708.
2. Chan, S. H., B. Perussia, J. W. Gupta, M. Kobayashi, M. Pospisil, H. A. Young, S. F. Wolf, D. Young, S. C. Clark, and G. Trincheri. 1991. Induction of interferon-gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869-879.
3. Clemons, K. V., E. Brummer, and D. A. Stevens. 1994. Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob. Agents Chemother. 38:460-466.
4. Coligan, J. E., A. M. Kruisbeek, D. M. Margulies, E. M. Schevach, and W. Strober. 1991. Current protocols in immunology. John Wiley & Sons, New York, N.Y.
5. Cusumano, V., F. Genovese, G. Mancuso, M. Carbone, M. T. Fera, and G. Teti. 1996. Interleukin-10 protects neonatal mice from lethal group B streptococcal infection. Infect. Immun. 64:2850-2852.
6. Cusumano, V., G. Mancuso, F. Genovese, M. Cuzzola, M. Carbone, J. A. Cook, J. B. Cochran, and G. Teti. 1997. Neonatal hypersusceptibility to endotoxin correlates with increased TNF production in mice. J. Infect. Dis. 176:168-176.
7. Cusumano, V., G. Mancuso, F. Genovese, D. Delfino, C. Beninati, E. Losi, and G. Teti. 1996. Role of gamma interferon in neonatal mouse model of group B streptococcal disease. Infect. Immun. 64:2941-2944.
8. D'Andrea, A., M. Rengaraju, N. M. Valiante, J. Chehimi, M. Kubin, M. Aste, S. H. Chan, M. Kobayashi, D. Young, E. Nicbarg, R. Chizzonite, S. F. Wolf, and G. Trincheri. 1992. Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells. J. Exp. Med. 176: 1387-1398.
9. Derrico, C. A., and K. J. Goodrum. 1996. Interleukin-12 and tumor necrosis factor alpha mediate innate production of gamma interferon by group B streptococcus-treated splenocytes of several combined immunodeficiency mice. Infect. Immun. 64:1314-1320.
10. Dinarello, C. A. 1991. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J. Infect. Dis. 163:1177-1184.
11. Flynn, J. L., M. M. Goldstein, K. J. Triebold, J. Sypek, S. F. Wolf, and B. R. Bloom. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155:2515-2524.
12. Freudenberg, M. A., Y. Kumazawa, S. Meding, J. Langhorne, and G. Galanos. 1991. Gamma interferon production in endotoxin-responder and -non-responder mice during infection. Infect. Immun. 59:3484-3491.
13. Gazzinelli, R. T., M. Wysocka, S. Hayashi, E. Y. Denkers, S. Hieny, P. Caspar, G. Trincheri, and A. Sher. 1994. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:2533-2543.
14. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin-12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505-1509.
15. Hill, H. R. 1993. Modulation of host defenses with interferon-γ in pediatrics. J. Infect. Dis. 167:523-528.
16. Hunter, C. A., T. Slifer, and F. Araujo. 1996. Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon. Infect. Immun. 64:2381-2386.
17. Jacobsen, S. E. W., O. P. Veiby, and E. B. Smeland. 1993. Cytotoxic lymphocyte modulation factor (interleukin-12) is a synergistic growth factor for hematopoietic stem cells. J. Exp. Med. 178:413-418.
18. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827-845.
19. Lewis, D. B., A. Larsen, and C. B. Wilson. 1986. Reduced interferon-γ mRNA levels in human neonates. J. Exp. Med. 163:1018-1023.
20. Locksley, R. M. 1993. Interleukin-12 in host defense against microbial pathogens. Proc. Natl. Acad. Sci. USA 90:5879-5880.
21. Mancuso, G., V. Cusumano, J. A. Cook, E. Smith, F. Squadrito, G. Blandino, and G. Teti. 1994. Efficacy of tumor necrosis factor alpha and eicosanoid inhibitors in experimental models of neonatal sepsis. FEMS Immunol. Med. Microbiol. 9:49-54.
22. Mancuso, G., F. Tomasello, M. Migliardo, D. Delfino, J. Cochran, J. A. Cook, and G. Teti. 1994. Beneficial effects of interleukin-6 in neonatal models of group B streptococcal disease. Infect. Immun. 62:4992-5002.
23. Manetti, R., P. Parronchi, M. G. Guidizi, M. P. Piccinni, E. Maggi, G. Trincheri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 (IL-12)) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199-1204.
24. Metzger, D. W., R. Reader, V. H. Van Cleave, and M. D. Boyle. 1995. Protection of mice from group A streptococcal skin infection by interleukin-12. J. Infect. Dis. 171:1643-1645.
25. Neurath, M. F., I. Fuss, B. L. Kelsall, E. Stuber, and W. Strober. 1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182:1281-1290.
26. Romani, L., A. Mencacci, L. Tonnetti, R. Spaccapelo, E. Cenci, S. F. Wolf, P. Puccetti, and F. Bistoni. 1994. IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J. Immunol. 153: 5167-5175.
27. Sedegah, M., F. Finkelman, and S. L. Hoffman. 1994. Interleukin-12 induction of interferon gamma-dependent protection against malaria. Proc. Natl. Acad. Sci. USA 91:10700-10702.
28. Seder, R. A., B. L. Kelsall, and D. Jankovic. 1996. Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. J. Immunol. 157:2745-2748.
29. Stevenson, M. M., M. K. Tam, S. F. Wolf, and A. Sher. 1995. IL-12-induced protection against blood-stage Plasmodium chabaudi requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155:2545-2556.
30. Teti, G., G. Mancuso, and F. Tomasello. 1993. Cytokine appearance and effects of anti-tumor necrosis factor antibodies in a neonatal rat model of group B streptococcal infection. Infect. Immun. 61:227-235.
31. Trincheri, G. 1993. Interleukin-12 and its role in the generation of Th 1 cells. Immunol. Today 14:335-337.
32. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory function that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276.
33. Tripp, C. S., M. K. Gately, J. Hakimi, P. Ling, and E. R. Unanue. 1994. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice: reversal by IFN-gamma. J. Immunol. 152:1883-1887.
34. Urban, J. F. J., R. Fayer, S. J. Chen, W. C. Gause, M. K. Gately, and F. D. Finkelman. 1996. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J. Immunol. 156:263-268.
35. Wang, Z. E., S. Zheng, D. B. Corry, D. K. Dalton, R. A. Seder, S. L. Reiner, and R. M. Locksley. 1994. Interferon γ-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc. Natl. Acad. Sci. USA 91:12932-12936.
36. Wilson, C. B. 1986. Immunologic basis for increased susceptibility of the neonate to infection. J. Pediatr. 108:111-116.
37. Wu, C. Y., C. Demeure, M. Kiniwa, M. Gately, and G. Delespesse. 1993. IL-12 induces the production of IFN-γ by neonatal human CD4 T cells. J. Immunol. 151:1938-1949.
38. Wynn, T. A., I. Eltoum, I. P. Oswald, A. W. Cheever, and A. Sher. 1994. Endogenous interleukin-12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J. Exp. Med. 179:1551-1561.